Bioventus Inc. (BVS)
USD 10.61
(-4.84%)
USD 10.61
(-4.84%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 512.34 Million | 512.11 Million | 430.89 Million | 321.16 Million | 340.14 Million | 319.17 Million |
| Cost of Revenue | 184.15 Million | 181.03 Million | 128.19 Million | 87.64 Million | 90.93 Million | 84.16 Million |
| Gross Profit | 328.19 Million | 331.08 Million | 302.7 Million | 233.51 Million | 249.2 Million | 235 Million |
| Operating Expenses | 409.91 Million | 379.7 Million | 281.65 Million | 211.71 Million | 217.43 Million | 207.64 Million |
| Selling, General and Administrative Expenses | 303.87 Million | 332.6 Million | 254.25 Million | 193.07 Million | 198.47 Million | 191.67 Million |
| Research and Development Expenses | 13.44 Million | 25.94 Million | 19.03 Million | 11.2 Million | 11.05 Million | 8.09 Million |
| Other Expenses | - | 21.15 Million | 8.36 Million | 7.43 Million | 7.9 Million | -226 Thousand |
| Cost and Expenses | 594.07 Million | 560.73 Million | 409.84 Million | 299.36 Million | 308.37 Million | 291.81 Million |
| Operating Income | -81.72 Million | -35.67 Million | 17.72 Million | 21.23 Million | 31.19 Million | 25.5 Million |
| Interest Expense | 40.67 Million | 25.79 Million | 1.11 Million | 9.75 Million | 21.57 Million | 19.17 Million |
| Income Tax Expense | 85 Thousand | -50.5 Million | -1.96 Million | 1.19 Million | 1.57 Million | 1.66 Million |
| Earnings before Tax | -121.11 Million | -263.89 Million | 7.62 Million | 15.91 Million | 9.68 Million | 6.1 Million |
| Net Income | -156.23 Million | -213.39 Million | 9.58 Million | 16.41 Million | 6.85 Million | -12.2 Million |
| Earnings Per Share Basic | -2.49 | -3.48 | 0.16 | 0.08 | -0.01 | -0.22 |
| Earnings Per Share Diluted | -2.49 | -3.48 | 0.16 | 0.08 | -0.01 | -0.22 |
| Weighted Average Shares Outstanding | 62.64 Million | 61.38 Million | 59.54 Million | 56.82 Million | 56.82 Million | 55.62 Million |
| Weighted Average Shares Outstanding (Diluted) | 62.64 Million | 61.38 Million | 59.54 Million | 56.82 Million | 56.82 Million | 55.62 Million |
| Gross Margin | 0.64 | 0.65 | 0.70 | 0.73 | 0.73 | 0.74 |
| EBIT Margin | -0.05 | 0.06 | 0.12 | 0.17 | 0.18 | 0.18 |
| Profit Margin | -0.30 | -0.42 | 0.02 | 0.05 | 0.02 | -0.04 |
| EBITDA | -23.07 Million | -109.2 Million | 51.8 Million | 50.44 Million | 61.58 Million | 54.51 Million |
| Earnings Before Tax Margin | -0.16 | -0.07 | 0.04 | 0.07 | 0.09 | 0.08 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 138.96 Million | 151.21 Million | 129.45 Million | 512.34 Million | 135.42 Million | 120.79 Million |
| Cost of Revenue | 45.41 Million | 49.64 Million | 42.83 Million | 192.99 Million | 51.22 Million | 41.94 Million |
| Gross Profit | 93.55 Million | 101.57 Million | 86.62 Million | 319.35 Million | 84.19 Million | 78.85 Million |
| Operating Expenses | 84.89 Million | 95.92 Million | 80.44 Million | 303.34 Million | 79.94 Million | 75.15 Million |
| Selling, General and Administrative Expenses | 81.09 Million | 91.94 Million | 77.84 Million | - | 76.68 Million | 69.82 Million |
| Research and Development Expenses | 3.8 Million | 3.98 Million | 2.59 Million | - | 3.26 Million | 3.01 Million |
| Other Expenses | - | -159 Thousand | -63 Thousand | 1.29 Million | 709 Thousand | -494 Thousand |
| Cost and Expenses | 130.31 Million | 145.57 Million | 123.27 Million | 496.33 Million | 131.16 Million | 117.09 Million |
| Operating Income | 4.07 Million | 5.64 Million | 6.18 Million | 16.01 Million | 4.25 Million | 2.41 Million |
| Interest Expense | 9.53 Million | 9.92 Million | 10.33 Million | 40.67 Million | 10.28 Million | 10.11 Million |
| Income Tax Expense | 589 Thousand | -7.33 Million | 907 Thousand | 85 Thousand | -750 Thousand | 600 Thousand |
| Earnings before Tax | -4.83 Million | -39.45 Million | -5.07 Million | -121.11 Million | -8.4 Million | -8.19 Million |
| Net Income | -4.82 Million | -23.99 Million | -4.57 Million | -156.23 Million | -6.09 Million | -7.3 Million |
| Earnings Per Share Basic | -0.07 | -0.37 | -0.07 | - | -0.10 | -0.12 |
| Earnings Per Share Diluted | -0.07 | -0.37 | -0.07 | - | -0.10 | -0.12 |
| Weighted Average Shares Outstanding | 65.25 Million | 64.05 Million | 63.38 Million | 62.64 Million | 63.1 Million | 62.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 65.25 Million | 64.05 Million | 63.38 Million | 62.64 Million | 63.1 Million | 62.82 Million |
| Gross Margin | 0.67 | 0.67 | 0.67 | 0.62 | 0.62 | 0.65 |
| EBIT Margin | 0.36 | 0.12 | 0.14 | - | 0.12 | 0.14 |
| Profit Margin | -0.03 | -0.16 | -0.04 | -0.30 | -0.05 | -0.06 |
| EBITDA | 50.71 Million | 18.73 Million | 17.97 Million | - | 16.71 Million | 17.03 Million |
| Earnings Before Tax Margin | 0.03 | 0.04 | 0.05 | 0.03 | 0.03 | 0.02 |
EPRT
ATDS
UBS
KR
3592
TRIBO-B